In concordance with the increased proportion of M2 in non-DE CD5+ DLBCL, the expression of immune checkpoint TIM3 (HAVCR2) was positively correlated with the proportion of M2 in our study. This evidence concerns the gene HAVCR2 and diffuse large B-cell lymphoma.